Replies to post #54696 on Avid Bioservices Inc (CDMO)

[MobyInvestor]

Define "require" please.

I'm going to assume that you fully comprehend what "require" means.

Now, if "common short-term side effects and risks associated with the drug" are safety issues and they are required to be evaluated during phase II, please explain the lack of any flagged safety issues for the primary or secondary outcome measures in 3 of the 5 phase II Bavi AC trials.

Regards,

moby